Early initiation of treatment for HIV infection

The Lancet

Volumn 375, Issue 9715, 2010, Pages 639-

  Phillips, Andrew ^a   Costagliola, Dominique ^b   Sabin, Caroline ^a   Sterne, Jonathan ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CLINICAL PRACTICE; DEATH; DISEASE COURSE; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 76749121793     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60269-3     Document Type: Letter

References (5)

1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf (accessed Feb 3, 2010).
2. Sterne J.A., May M., Costagliola D., et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 373 (2009) 1352-1363
3. Kitahata M.M., Gange S.J., Abraham A.G., et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 360 (2009) 1815-1826
4. INSIGHT START trial. http://insight.ccbr.umn.edu/start/ (accessed Feb 3, 2010).
5. Hernan M.A., and Robins J.M. Early versus deferred antiretroviral therapy for HIV. N Engl J Med 361 (2009) 822-824